Diabetes and obesity: treatment and trials update
European Pharmaceutical Review reports on some of the latest developments in treatments for type 2 diabetes and obesity.
List view / Grid view
European Pharmaceutical Review reports on some of the latest developments in treatments for type 2 diabetes and obesity.
A study has shown that thousands of heart attacks and deaths caused by cardiovascular disease could be prevented through the use of statins...
“We will work with health care professionals and patients to develop a form of rehabilitation that will be acceptable to all those involved."
Health Data Research UK is awarding £30 million funding to six sites across the UK to address challenging healthcare issues through the use of data science...
Pharmaceutical companies are sponsoring a project to generate, align and share disease-level data across an entire condition for health technology assessments...
Researchers have identified that the drug semaglutide resulted in better glycemic control than placebo for patients with type 2 diabetes...
US science minister announce new multi-million-pound commitment to boost the burgeoning field of cryo-electron microscopy (cryo-EM) in the UK.
New research projects that aim to improve the complex formulation processes used to manufacture products such as toothpastes, inhalers, films that coat solar cells and pharmaceuticals are to receive significant funding from the Engineering and Physical Sciences Research Council (EPSRC).
21 July 2016 | By Niamh Louise Marriott, Digital Content Producer
global pharmaceutical company GlaxoSmithKline has been established to discover and develop novel medicines to treat aggressive forms of blood cancer...
10 May 2016 | By Victoria White, Digital Content Producer
Researchers have shown a modified dosage rtPA can reduce serious bleeding in the brain and improve survival rates in patients with acute stroke...
11 November 2015 | By Victoria White
The clinical trial, a first-in-man study, looked at the efficacy of ONO/GS-4059 in the treatment of Chronic Lymphocytic Leukaemia and Non-Hodgkin Lymphoma patients...